Dr. Maja Green

Dr. Maja Green is a biomedical scientist, clinical trialist, and research executive with multidisciplinary expertise spanning neuromodulation, psychopharmacology, pain neuroscience, and digital health. She currently serves as Chief Scientific Officer at NXTSTIM Inc., where she leads the scientific development and clinical strategy for EcoAI™, an FDA-cleared, AI-driven wearable neuromodulation system for chronic pain management.

​

Dr. Green is also the Co-Founder and Co-Owner of Solaris Research Institute, an international research organization operating across the United States and Australia. Solaris specializes in decentralized, technology-enabled clinical trials focused on non-opioid pain therapeutics, mental health, and digital therapeutics. In her dual leadership role, Dr. Green has built transcontinental clinical research programs and oversees protocol development, regulatory operations, and strategic collaborations with academic and industry partners.

​

In addition, she is Director of Research at the Innovative Pain Treatment Solutions (IPTS) in San Diego, where she supports investigator-initiated research on chronic pain, neurotrauma, and emerging device-based treatments.

​

Dr. Green holds a PhD in Biomedical Sciences and an MBA with distinction, giving her a rare dual fluency in scientific innovation and health-tech business strategy. She has authored peer-reviewed publications in anesthesiology, neuroscience, and psychopharmacology, and regularly leads regulatory-grade studies aimed at generating real-world evidence for reimbursement and clinical adoption.

​

She is an active contributor to scientific discourse on opioid-sparing strategies, AI-integrated neuromodulation, and patient-centered trial design, and is known for her ability to translate emerging science into clinically actionable innovation.